发明名称 Rxr Antagonists in the Treatment of Inflammatory Diseases
摘要 Retinoids with retinoid antagonistic activities, especially Retinoid X Receptor antagonists called RXR antagonists, pharmaceutically acceptable salts and pharmaceutically acceptable esters and amides thereof, have been found to be efficacious in the treatment of inflammatory diseases of the skin and mucous membranes, and of other tissues and organs for example by topical or oral administration of RXR antagonists.
申请公布号 US2008242729(A1) 申请公布日期 2008.10.02
申请号 US20050658716 申请日期 2005.07.16
申请人 BOLLAG WERNER 发明人 BOLLAG WERNER
分类号 A61K31/192;A61P29/00 主分类号 A61K31/192
代理机构 代理人
主权项
地址